Drug Repurposing May Provide More Psychiatric Tx Options

Drug Repurposing May Provide More Psychiatric Tx Options FRIDAY, Jan. 11, 2019 -- Three classes of drugs hold potential as repurposed agents to treat patients with serious mental illness, according to a study published online Jan. 9 in JAMA Psychiatry.

ProAir Digihaler Approval History

ProAir Digihaler Approval History Reviewed by J.Stewart BPharm. Last updated on Dec 26, 2018. FDA Approved: Yes (First approved December 21, 2018) Brand name: ProAir Digihaler Generic name: albuterol sulfate Dosage form: Inhalation Powder Compan

Vaxelis Approval History

Vaxelis Approval History Reviewed by J.Stewart BPharm. Last updated on Dec 30, 2018. FDA Approved: Yes (First approved December 21, 2018) Brand name: Vaxelis Generic name: diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivate

December 29, 30, 2018, January 1, 2019 is a holiday, January 2, 2019 normal work.

FDA Approves Vaxelis FDA Approves Vaxelis Pediatric Hexavalent Combination Vaccine

FDA Approves Vaxelis FDA Approves Vaxelis Pediatric Hexavalent Combination Vaccine BRIDGEWATER, N.J. and KENILWORTH, N.J. – December 26, 2018 –The U.S. Food and Drug Administration has approved Vaxelis™ (Diphtheria and Tetanus Toxoids and Acellular Pe

Horizon Pharma plc Announces FDA Approval to Expand the Age Range for Ravicti (glycerol phenylbutyrate) Oral Liquid to Include Newborns Facebook Twitter Email to a friend Print this page

Horizon Pharma plc Announces FDA Approval to Expand the Age Range for Ravicti (glycerol phenylbutyrate) Oral Liquid to Include Newborns DUBLIN--(BUSINESS WIRE)--Dec. 27, 2018-- Horizon Pharma plc (NASDAQ: HZNP) today announced the U.S. Food and Drug Admi